The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report
Journal of International Medical Research · 2023
DOI: 10.1177/03000605231162443 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of International Medical Research, 2023. Verfasst von Ting Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Soft Tissue Neoplasms, Kidney Neoplasms. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Skin and soft tissue diffusion metastasis (also known as occult cancer) is rare in renal cell carcinoma (RCC). Here, we report an extremely rare case of a 67-year-old male patient with occult primary RCC who developed metastases to the gums, skin, and diffuse soft tissue. The primary renal lesion was missed by computed tomography (CT), ultrasound, and 18F-fluorodeoxyglucose positron emission tomography (PET)/CT, and the diagnosis was confirmed by biopsy of gums and subcutaneous nodules. Subsequent enhanced CT revealed a lesion in the left kidney. The patient had progression-free survival of 16 months after treatment with axitinib and pembrolizumab. Pseudoprogression and tumor heterogeneity pose major challenges in the evaluation of immunotherapy. PET/CT is indispensable especially for cases with multiple metastases, widespread distribution of lesions, and major heterogeneity. In this case, the total lesion glycolysis was calculated by PET/CT and was used to evaluate systemic tumor load before and after immunotherapy, which was calculated as the product of the metabolic tumor volume and the mean standardized uptake value of the target lesion, which increased the accuracy of assessing diffuse lesions. Total lesion glycolysis can be used as a new method to quantitatively evaluate the efficacy of immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
- Department of Medicine Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
- Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
ORCID-Profile: Jianfei Fu
Zitieren
APA
Jiang, T., Zheng, H., Dong, K., Guanghua, W., Zhou, S., Li, C., Dong, M., & Fu, J. (2023). The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report. Journal of International Medical Research. https://doi.org/10.1177/03000605231162443
Vancouver
Jiang T, Zheng H, Dong K, Guanghua W, Zhou S, Li C, et al. The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report. Journal of International Medical Research. 2023. doi:10.1177/03000605231162443
BibTeX
@article{Jiang2023,
author = {Jiang, Ting and Zheng, Hongjuan and Dong, Ke and Guanghua, Wen and Zhou, Shishi and Li, Chenghui and Dong, Mengjie and Fu, Jianfei},
title = {The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report},
journal = {Journal of International Medical Research},
year = {2023},
doi = {10.1177/03000605231162443}
}
EUVIMED